Supra-physiological efficacy at GPCRs: superstition or super agonists?

Research output: Contribution to journalArticleOtherpeer-review

Abstract

The concept of super agonism has been described since the discovery of peptide hormone analogues that yielded greater functional responses than the endogenous agonists, in the early 1980s. It has remained an area of debate as to whether such compounds can really display greater efficacy than an endogenous agonist. However, recent pharmacological data, combined with crystal structures of different GPCR conformations and improved analytical methods for quantifying drug action, are starting to shed light on this phenomenon and indicate that super agonists may be more than superstition.
Original languageEnglish
Pages (from-to)353 - 356
Number of pages4
JournalBritish Journal of Pharmacology
Volume169
Issue number2
DOIs
Publication statusPublished - 2013

Cite this

@article{2065c38b57ba456b89bb60e0b028f49d,
title = "Supra-physiological efficacy at GPCRs: superstition or super agonists?",
abstract = "The concept of super agonism has been described since the discovery of peptide hormone analogues that yielded greater functional responses than the endogenous agonists, in the early 1980s. It has remained an area of debate as to whether such compounds can really display greater efficacy than an endogenous agonist. However, recent pharmacological data, combined with crystal structures of different GPCR conformations and improved analytical methods for quantifying drug action, are starting to shed light on this phenomenon and indicate that super agonists may be more than superstition.",
author = "Langmead, {Christopher J} and Arthur Christopoulos",
year = "2013",
doi = "10.1111/bph.12142",
language = "English",
volume = "169",
pages = "353 -- 356",
journal = "British Journal of Pharmacology",
issn = "1476-5381",
publisher = "Wiley-Blackwell",
number = "2",

}

Supra-physiological efficacy at GPCRs: superstition or super agonists? / Langmead, Christopher J; Christopoulos, Arthur.

In: British Journal of Pharmacology, Vol. 169, No. 2, 2013, p. 353 - 356.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - Supra-physiological efficacy at GPCRs: superstition or super agonists?

AU - Langmead, Christopher J

AU - Christopoulos, Arthur

PY - 2013

Y1 - 2013

N2 - The concept of super agonism has been described since the discovery of peptide hormone analogues that yielded greater functional responses than the endogenous agonists, in the early 1980s. It has remained an area of debate as to whether such compounds can really display greater efficacy than an endogenous agonist. However, recent pharmacological data, combined with crystal structures of different GPCR conformations and improved analytical methods for quantifying drug action, are starting to shed light on this phenomenon and indicate that super agonists may be more than superstition.

AB - The concept of super agonism has been described since the discovery of peptide hormone analogues that yielded greater functional responses than the endogenous agonists, in the early 1980s. It has remained an area of debate as to whether such compounds can really display greater efficacy than an endogenous agonist. However, recent pharmacological data, combined with crystal structures of different GPCR conformations and improved analytical methods for quantifying drug action, are starting to shed light on this phenomenon and indicate that super agonists may be more than superstition.

UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=23441648

U2 - 10.1111/bph.12142

DO - 10.1111/bph.12142

M3 - Article

VL - 169

SP - 353

EP - 356

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 1476-5381

IS - 2

ER -